SCHEMBL31421132

SCHEMBL31421132

CC(C)(C)OC(=O)N1CC[C@@H](NCCN)C1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.53
USP30 Q70CQ3 10/20 0.47
CYP2C9 P11712 1/20 0.44
HSD11B1 P28845 1/20 0.44
ALDH1A1 P00352 3/20 0.44
PARP1 P09874 1/20 0.44
MAPT P10636 2/20 0.43
NPC1 O15118 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HPGD P15428 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20986886 0.93 USP30 (0.51) EPHX1USP30ALDH1A1PARP1MAPT
SCHEMBL20986582 0.93 USP30 (0.51) EPHX1USP30ALDH1A1PARP1MAPT
SCHEMBL3571988 0.92 EPHX1 (0.59) EPHX1ALDH1A1MAPTNPC1MAPK1
SCHEMBL25237250 0.89 EPHX1 (0.52) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL13696753 0.89 EPHX1 (0.52) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL18556969 0.89 EPHX1 (0.52) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL18834717 0.88 NR1H2 (0.48) EPHX1USP30ALDH1A1PARP1MAPT
SCHEMBL23555643 0.87 EPHX1 (0.51) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL13712553 0.85 USP30 (0.49) EPHX1USP30CYP2C9HSD11B1ALDH1A1
SCHEMBL24033437 0.85 EPHX1 (0.49) EPHX1USP30CYP2C9HSD11B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-04-24 US disclosed
WO-2025064718-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS EPHX1 4188/4885USP30 1751/4885CYP2C9 4209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.